Botanical species · safety record

Desmodium adscendens

The EFSA Compendium of Botanicals holds 10 constituent measurements and 4 adverse-effect records for Desmodium adscendens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Desmodium adscendens (Sw.) DC.

10Constituent measurements

4Safety records

7Cited sources

6Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Desmodium adscendens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Grass(es)
Herb
Leaf
Plante entière

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Mass Spectroscopy and hyphenated methods without chromatography	Resolve DOI
Hordenine	Leaves	Solvent extraction	—	Mass Spectroscopy and hyphenated methods without chromatography	Resolve DOI
Salsoline	Leaves	Solvent extraction	—	Mass Spectroscopy and hyphenated methods without chromatography	Resolve DOI
Saponins	Leaves	Solvent extraction	—	Mass Spectroscopy and hyphenated methods without chromatography	Resolve DOI
Triterpene saponins	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Triterpene saponins	Aerial part of plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Tyramine	Aerial part of plants	Solvent extraction	—	Unspecified	Resolve DOI
Gallic acid	Leaves	Solvent extraction	0.14 Gram/litre	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
P-coumaric acid	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
P-coumaric acid	Leaves	Solvent extraction	0.09 Gram/litre	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Systemic	—	Aerial part of plants	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI
Systemic	—	Aerial part of plants	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI
Systemic	—	Aerial part of plants	Solvent extraction	House mouse (as animal)	Acute toxicity	Resolve DOI
Systemic	—	Aerial part of plants	Solvent extraction	House mouse (as animal)	Acute toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Rammal, H., Soulimani, R. Immunoactive profile of aqueous extracts of Desmodium adscendens in mice. Journal of herbs, spices and medicinal plants, 2011, vol. 17, no. 2, p. 154-168. DOI
Asante, Kojo Isaac., Amuzu, Nancy., Donkor, Augustine., Annan, Kofi. Screening of some Ghanaian medicinal plants for phenolic compounds and radical scavenging activities. Pharmacognosy journal, 2009, vol. 1, no. 3, p. 201-206.
Baiocchi, Claudio., Medana, Claudio., Giancotti, Valeria., Aigotti, Riccardo., Dal Bello, Frederica., Massolino, Cristina., Gastaldi, Daniela., Grandi, Maurizio. Qualitative characterization of Desmodium adscendens constituents by high-performance liquid chromatography-diode array ultraviolet-electrospray ionization multistage mass spectrometry . European journal of mass spectrometry, 2013, vol. 19, no. 1, p. 1-15. DOI
ADDY, ME., SCHWARTZMAN, ML. AN EXTRACT OF DESMODIUM ADSCENDENS ACTIVATES CYCLOOXYGENASE AND INCREASES PROSTAGLANDIN SYNTHESIS BY RAM SEMINAL-VESICLE MICROSOMES . Phytotherapy research, 1995, vol. 9, no. 4, p. 287-293. DOI
MCMANUS, OB., HARRIS, GH., GIANGIACOMO, KM., FEIGENBAUM, P., REUBEN, JP., ADDY, ME., BURKA, JF., KACZOROWSKI, GJ., GARCIA, ML. AN ACTIVATOR OF CALCIUM-DEPENDENT POTASSIUM CHANNELS ISOLATED FROM A MEDICINAL HERB . Biochemistry, 1993, vol. 32, no. 24, p. 6128-6133. DOI
Addy, M.E. Several chromatographically distinct fractions of desmodium adscendens inhibit smooth muscle contractions. Pharmaceutical biology, 1989, vol. 27, no. 2, p. 81-91. DOI
Muanda, Francois N., Soulimani, Rachid., Dicko, Amadou. Study on biological activities and chemical composition of extracts from Desmodium adscendens leaves. Journal of natural products (gorakhpur, india), 2011, vol. 4, p. 100-107.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature